Overview of Dr. Verna
Dr. Elizabeth Verna is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 14 years. Dr. Verna accepts several types of health insurance, listed below. She is one of 300 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Gastroenterology. She has more than 100 publications and over 500 citings.
Office
622 W 168th St
New York, NY 10032Fax+1 212-305-4343
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Transplant Hepatology, 2010 - 2011
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Gastroenterology, 2007 - 2010
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2003 - 2006
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2003
Certifications & Licensure
- NY State Medical License 2005 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant Start of enrollment: 2012 Mar 01
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
- Boceprevir in End Stage Renal Disease (ESRD) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis.Giuseppe Cullaro, Andrew S Allegretti, Kavish R Patidar, Elizabeth C Verna, Jennifer C Lai
Liver Transplantation. 2025-01-01 - 1 citationsFaecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis.Henriette Kreimeyer, Carlos G Gonzalez, Marcos F Fondevila, Cynthia L Hsu, Phillipp Hartmann
Gut. 2024-12-10 - The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone.Melinda Wang, Amy M Shui, Chiung-Yu Huang, Matthew R Kappus, Robert Rahimi
Liver Transplantation. 2024-12-01
Other
- Liver transplantation for hepatitis C virus infectionVerna EC, Brown RS
http://www.uptodate.com/contents/liver-transplantation-for-hepatitis-c-virus-infection
UpToDate, Wolters Kluwer Health - 2013-01-22
Press Mentions
- NIH Grant Funds Clinical Research on CirrhosisOctober 15th, 2021
- Target RWE COVID-19 Data: Real-World Evidence Analysis Shows 3.6% of COVID-19 Hospitalized Patients Discharged Alive Required ReadmissionMay 25th, 2021
- Study: Frailty Is a Risk Factor Among Women Waiting for Liver TransplantsDecember 30th, 2020
- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
Empire BCBS HMOEmpire BCBS PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: